http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4870066-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fcb093a174d5182b5854b704cb09354 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate | 1986-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1989-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80eecd59dffc13513ed840b6a4a75e46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21c023634d2c07a3a25489625d8e7efc |
| publicationDate | 1989-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4870066-A |
| titleOfInvention | Method and composition for safely delaying parturition and synchronizing farrowing in swine |
| abstract | A method and composition are provided for extending the gestation period of a sow so as to increase the live birth and survival rates of a swine litter without adversely affecting the sow. The method includes the step of administering an effective dosage of estrogen to the sow 21/2-7 days prior to the end of the expected gestation period for the sow. The composition administered includes from 0.5-10 mg of an estrogen selected from a group consisting of estradiol benzoate, estradiol valerate, estrone, estradiol 17 beta and effective mixtures thereof. The composition is adapted for administration parenterally by including a carrier such as corn oil. A method is also provided for synchronizing farrowing in a herd of swine bred following synchronized weaning so as to shorten the target period during which all the sows of the herd begin farrowing. This method involves the administration of a farrowing delaying composition including estrogen as an active ingredient in combination with the administration of an effective dosage of a farrowing inducing composition that may include a prostaglandin as the active ingredient. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5369128-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5095010-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004074447-A1 |
| priorityDate | 1986-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 90.